- Home
- ALVO vs GOF Comparison
ALVO vs GOF Comparison
Compare ALVO & GOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALVO
- GOF
- Stock Information
- Founded
- ALVO 2013
- GOF 2006
- Country
- ALVO Luxembourg
- GOF United States
- Employees
- ALVO N/A
- GOF N/A
- Industry
- ALVO Biotechnology: Pharmaceutical Preparations
- GOF Finance/Investors Services
- Sector
- ALVO Health Care
- GOF Finance
- Exchange
- ALVO Nasdaq
- GOF Nasdaq
- Market Cap
- ALVO 2.5B
- GOF 2.4B
- IPO Year
- ALVO N/A
- GOF N/A
- Fundamental
- Price
- ALVO $9.19
- GOF $14.92
- Analyst Decision
- ALVO Buy
- GOF
- Analyst Count
- ALVO 1
- GOF 0
- Target Price
- ALVO $18.00
- GOF N/A
- AVG Volume (30 Days)
- ALVO 187.6K
- GOF 789.2K
- Earning Date
- ALVO 08-14-2025
- GOF 01-01-0001
- Dividend Yield
- ALVO N/A
- GOF 15.42%
- EPS Growth
- ALVO N/A
- GOF N/A
- EPS
- ALVO 0.34
- GOF N/A
- Revenue
- ALVO $587,890,000.00
- GOF N/A
- Revenue This Year
- ALVO $35.07
- GOF N/A
- Revenue Next Year
- ALVO $44.61
- GOF N/A
- P/E Ratio
- ALVO $27.11
- GOF N/A
- Revenue Growth
- ALVO 413.92
- GOF N/A
- 52 Week Low
- ALVO $7.35
- GOF $10.96
- 52 Week High
- ALVO $13.70
- GOF $16.76
- Technical
- Relative Strength Index (RSI)
- ALVO 43.33
- GOF 61.54
- Support Level
- ALVO $8.86
- GOF $14.76
- Resistance Level
- ALVO $9.51
- GOF $14.95
- Average True Range (ATR)
- ALVO 0.31
- GOF 0.12
- MACD
- ALVO -0.06
- GOF 0.03
- Stochastic Oscillator
- ALVO 43.03
- GOF 100.00
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.
About GOF Guggenheim Strategic Opportunities Fund of Beneficial Interest
Guggenheim Strategic Opportunities Fund is a diversified, closed-end management investment company. The investment objective of the firm is to maximize total return through a combination of current income and capital appreciation. The Fund seeks to combine a credit-managed fixed-income portfolio with access to a diversified pool of alternative investments and equity strategies.